Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis
Status:
Completed
Trial end date:
2005-12-21
Target enrollment:
Participant gender:
Summary
The purpose of this study of this study is to investigate the safety, tolerability and
pharmacokinetics of GW842470X in patients with atopic dermatitis. GW842470X is an inhibitor
of phosphodiesterase 4 (PDE4).